Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood
Yingping Wu, Tiejun Zhao, Riqiang Deng, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Exosomes: Potential Disease Biomarkers and New Therapeutic Targets
María Isabel Mosquera Heredia, Luis Carlos Morales, Oscar M. Vidal, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1061-1061
Open Access | Times Cited: 97
The role of noncoding RNAs in Parkinson’s disease: biomarkers and associations with pathogenic pathways
Ming‐Che Kuo, Sam Chi-Hao Liu, Ya-Fang Hsu, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 71
Circular RNA circ‐TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA
Xiaojuan Pan, Bo Huang, Qiang Ma, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 54
Unwinding circular RNA’s role in inflammatory pulmonary diseases
Asif Ahmad Bhat, Gaurav Gupta, Ahsas Goyal, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2567-2588
Closed Access | Times Cited: 40
A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection
S Narayanan, David A. Jamison, Joseph W. Guarnieri, et al.
European Journal of Human Genetics (2023) Vol. 32, Iss. 1, pp. 10-20
Open Access | Times Cited: 29
Noncoding RNAs in the COVID-19 Saga: An Untold Story
Mudasir Maqbool, Md Sadique Hussain, Nusrat K. Shaikh, et al.
Viral Immunology (2024) Vol. 37, Iss. 6, pp. 269-286
Closed Access | Times Cited: 9
Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments
Sangiliyandi Gurunathan, Min-Hee Kang, Jin‐Hoi Kim
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 53
The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization
Reza Keikha, Seyed Mohammad Hashemi‐Shahri, Ali Jebali
European journal of medical research (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 44
Sensitive, reliable and robust circRNA detection from RNA-seq with CirComPara2
Enrico Gaffo, Alessia Buratin, Anna Dal Molin, et al.
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 42
Circular RNAs and Their Role in Exosomes
Zeping Han, Huafang Chen, Zhonghui Guo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 35
The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection
Yuhao Lin, Qiqi Sun, Bao Zhang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 17
Long Noncoding RNAs as Emerging Regulators of COVID-19
Qinzhi Yang, Lin Fang, Yanan Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 38
Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells
Davide Barbagallo, Concetta Ilenia Palermo, Cristina Barbagallo, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 2
Open Access | Times Cited: 24
The role of non-coding RNAs in the diagnosis of different stages (HCC, CHB, OBI) of hepatitis B infection
Omid Gholizadeh, Sama Akbarzadeh, Masood Moein, et al.
Microbial Pathogenesis (2023) Vol. 176, pp. 105995-105995
Closed Access | Times Cited: 13
Circular RNAs in human diseases
Yuanyong Wang, Jin Zhang, Yu‐Chen S. H. Yang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 5
Non-Coding RNAs in COVID-19: Emerging Insights and Current Questions
Tobias Plowman, Dimitris Lagos
Non-Coding RNA (2021) Vol. 7, Iss. 3, pp. 54-54
Open Access | Times Cited: 27
RETRACTED: Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance
Hanieh Shirvani, Hanieh Jafari, Sayyed Sajjad Moravveji, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 1538-1550
Open Access | Times Cited: 19
Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics
Kaifee Arman, Zeinab Dalloul, Esra Bozgeyik
Gene (2023) Vol. 861, pp. 147232-147232
Open Access | Times Cited: 11
Intrinsic factors behind long‐COVID: I. Prevalence of the extracellular vesicles
Yousra A. El‐Maradny, Alberto Rubio‐Casillas, Vladimir N. Uversky, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 5, pp. 656-673
Closed Access | Times Cited: 11
Non-coding RNAs expression in SARS-CoV-2 infection: Pathogenesis, clinical significance and therapeutic targets
Xiaoxing Liu, Wandi Xiong, Maosen Ye, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Circular RNAs in the pathogenesis of SARS-CoV-2: potential diagnostic biomarkers and therapeutic targets
Jiajie Wu, Lele Li, Wei Xu, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Emerging role and clinical applications of circular RNAs in human diseases
Subhayan Sur, Jayanta K. Pal, Shashank Shekhar, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells
Sara Ahmadi Badi, Amin Malek, Alessandro Paolini, et al.
Microbial Pathogenesis (2022) Vol. 173, pp. 105798-105798
Open Access | Times Cited: 17
Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity
Zeynab Rahni, Seyed Masoud Hosseini, Shabnam Shahrokh, et al.
Virus Research (2023) Vol. 336, pp. 199214-199214
Open Access | Times Cited: 9
Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve?
Nadia Μ. Hamdy, Fatma H. Shaker, Xianquan Zhan, et al.
The EPMA Journal (2022) Vol. 13, Iss. 2, pp. 261-284
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top